Abstract-The literature data on glycine metabolism in neural tissue, the mitochondrial Gly cleaving sys tem, and the Gly uptake system in neural and glial cells are summarized. Brief description of localization and abundance of glycine receptors and specific binding sites in the mammalian nervous tissue is given. Four types of glycine binding receptors are described. These include own specific glycine receptor (GlyR), ionotropic glutamate receptor, which selectively binds N methyl D aspartate selectively (NMDAR), and ionotropic receptors of γ aminobutyrate (GABA A R, GABA C R).
INTRODUCTION
Glycine (Gly) exhibits various vitally important functions in the body [1−9] . It was found in various proteins and biologically active proteins; it is an immediate precursor for synthesis of the heme por phyrin moiety and a component for synthesis of purine bases [10] . This amino acid is also involved in regula tion of neurotransmitter synaptic transmission and the central and peripheral nervous system [1, 7] . Gly receptors localized in various regions of the brain and spinal cord mediated the inhibitory action on neurons and thus reduce release of excitatory amino acids [1⎯3] . Gly also acts as a co agonist of γ amino butyrate receptor (GABAR) and glutamate NMDA receptor (NMDAR) [4−8] .
Although Gly based pharmacological preparations demonstrate a wide range of positive effects (e.g., improvement of memory and associative processes, the antidepressant action, reduced feelings of anxiety, fear, psychoemotional stress, etc.), mechanisms responsible for their realization still require better understanding and in most even the best studied links of these mechanisms are based on numerous hypothe sis rather than well documented facts.
Possible Gly effects on viability of cultured nervous tissue cells remain poorly investigated as most studies in this field do investigate bioelectric activity of cell membranes influenced by Gly as a neurotransmitter [7−9, 11, 12] .
However, it has been recently demonstrated that Gly in the range of concentrations from 0.01 to 25.0 mM attenuates degenerative processes in the spi 1 To whom correspondence should be addressed. nal cord cell layer and C6 glioma induced by serum (trophic factor) deprivation [13−20] . During the whole period of observation (72 h) decreased activity of 2 calpain (EC 3.4.22.53), lactate dehydrogenase (EC 1.1.1.27) was registered in cells and conditioned media of these cultures; this was also accompanied by decreased cell death and maintenance of proliferative activity in the nerve tissue cells [13−19] . Gly addition also caused a 2⎯7 fold increase in spinal cord cell sur vival [20] . Under conditions of prolonged serum dep rivation in the cultural medium 0.1 mM Gly exhibited the mitogenic effect on rat spinal cord cells (14 days in vitro): there was an increase in cell DNA content and appearance of young neurons in the culture [13, 16] .
It was found that Gly critically influenced plasmi nogen effects. For example, 0.01 or 0.1 mM Gly added together with plasminogen (10 -7 M) potentiated the protector effect of this zymogen on C6 and spinal cord cells; in the presence of 10 -8 M plasminogen Gly increased the stimulating effect of this zymogen on C6 glioma cells. The stabilizing action was observed at both morpho functional and metabolic effects [14, 17, [20] [21] [22] .
These numerous Gly effects on the nervous tissue in vitro suggest a very important role of this amino acid for regulation of viability of nervous tissue cells (par ticularly, changes in cell cycle, cell protection against various damaging factors, principal changes in the mode of action of proteins exhibiting neurotrophic (plasminogen like) properties on target cells. Detailed elucidation of their mechanisms will clearly open per spectives for subsequent multidisciplinary studies.
GLYCINE METABOLISM IN THE NERVOUS TISSUE
Although glycine has been identified in proteins more than 200 years ago, studies on its dynamic con tent in various brain structures still cause scientific debates [23, 24] .
Brain content of Gly (and GABA as well) prevails (in the reducing order) in such structures as midbrain, thalamus, cerebellum, temporal cortex, and corpus collosum [24] . It is generally accepted that the brain content of free Gly is normally 1.3 μM and in the cere brospinal fluid it is two orders of magnitude less. Since Gly consumption in the nervous tissue is rather high and its supply from blood occurs rather slowly, the brain synthesizes a significant proportion of Gly de novo [25] .
Glucose and serine are the major sources for Gly biosynthesis in the central nervous system (CNS) [24] . Serine may be formed from glucose via 3 phospho glycerate formation; in addition, it is readily pene trates from blood circulation into the brain across the blood brain barrier. In the nervous tissue Gly synthesis de novo involves serine hydroxymethyltransferase (EC 2.1.2.1) [25] . High activity of this enzyme was found in metabolic pools of the brain and spinal cord, for example, in the cerebellum and the anterior horn of the spinal cored. Serine hydroxymethyltransferase activity correlated first of all with glycine content in these structures [2] .
Two other sources for Gly synthesis in the human and animal nervous systems include glutamate and glyoxylate [24] . Since brain glutamate concentration (about 10.6 μM) is the highest among amino acids, while glyoxylate concentrations are insignificant, glutamate makes the major contribution to Gly for mation. Glutamine, a precursor of both excitatory (Glu, Asp) and inhibitory (GABA, Gly) amino acid neurotransmitters enters neurons from the glia [26] .
At least three pathways of Gly catabolism do exist in the nervous tissue [24] . The first one is based on reversibility of the reaction of Ser conversion into Gly in the brain tissue and therefore serine hydroxymeth yltransferase may act as the Gly metabolizing enzyme [24, 27] . The second pathway involves oxidases of amino acids (EC 1.4.3.2, 1.4.3.3); in the CNS these highly abundant enzymes use Gly and other amino acids as substrates [24, 27, 28] . The third system of Gly cleavage is localized only in mitochondria and is atyp ical amino acid decarboxylase as its activity depends on both NAD + and tetrahydrofolate (THF) [24] . The Gly cleavage system catalyzes Gly cleavage into meth ylenetetrahydrofolate, carbon dioxide, and ammonia; methylene THF undergoes further oxidation with carbon dioxide formation, the end product of this amino acid [24] .
The Gly cleavage systems were found not only in neuronal cells, but also in astrocytes [29] [30] [31] . This is consistent with abundance of metabolic reactions in the nervous tissue in accordance with functional fea tures of cell types. The brain mitochondrial Gly cleavage system includes four components: P protein (pyridoxal phos phate dependent glycine decarboxylase), T protein (THF dependent aminomethyl transferase), H pro tein (containing lipoic acid as proton carrier), and L protein (lipoamide dehydrogenase) [29] [30] [31] .
In situ hybridization analysis has shown that pro tein P mRNA is prefentially expressed in glia like cells (including Bergmann glia in the cerebellum), while T and H protein mRNAs are registered in neurons and glia like cells [29] .
Only expression of T and H protein mRNAs was found in the spinal cord; the primary culture of spinal cord astrocytes contained only the proton car rier (H protein) lacking any enzymatic activity. It should be noted that the activity of the mitochondrial Gly cleavage system was higher in the primary culture of rat brain cortex astrocytes than in hepatocytes [29] .
In the spinal cord and the brainstem Gly functions as an inhibitory neurotransmitter, while in the hippoc ampus, brain cortex, cerebellum, and the olfactory bulb it acts as the stimulating modulator of NMDAR [29] . Analysis of literature data suggests that the Gly cleavage system is involved in pathogenesis of non ketotic hyperglycemia via modulation of NMDAR in the anterior brain and the cerebellum.
Consequently, Gly metabolism includes various catabolic and anabolic processes, which have several intersecting (cross talk) points, and may be summa rized into the scheme of Gly metabolism (Fig. 1) . These cross talks allow one processes to prevail over the other ones. For example, in rat brain astricytes the activity of the mitochondrial Gly cleavage system in higher than the activity of enzymes catalyzing reverse conversion of Gly into serine and therefore probability of Gly cleavage in astrocytes is higher than its use for serine formation [31] .
The spinal cord has high and low affinity systems of Gly uptake (K m < 0.05 mM and K m > 0.1 mM, respec tively), while the brain cortex has only the low affinity uptake system [24] .
It is generally believed that in the brain Gly is pref erentially involved in activation of the glutamate receptor [32, 33] : activation of NMDAR requires ago nist concentrations of about 0.0001⎯0.1 mM. In this case it is reasonable to suggest poor (if any) contribu tion of the low affinity uptake system of the brain into regulation of cortical cell functioning.
However, it should be also noted that brain Gly concentrations were evaluated in a pool (mass) of the tissue or the brain cortex. The latter cannot rule out that at certain time interval and in certain sites physi ological concentrations of this amino acid may be rea sonably high for involvement of the low affinity uptake system into physiological functioning of Gly. This problem clearly needs further investigation.
Transfer of neurotransmitter amino acids across the hydrophobic part of nerve cell membranes involves special Na + /Cl -dependent transporter proteins, which recognize, bind, and then transport the neu rotransmitters from the intracellular space into the cell or from the cell [34] . Members of the superfamily of Na + /Cl -dependent neurotransmitter transporters are type III membrane proteins that span the plasma membrane 12 times. According to secondary structure this family is subdivided into two subfamilies: classic members (GABA, Gly, β alanine, proline, dopamine, noradrenaline, and serotonin transporters) and so called orphans (with unknown transportable neu rotransmitters) [34] .
The main Gly transporters (GLYT1, GLYT2) are found in neurons and astroglia. For example, GLYT1 preferentially localized in astrocytes associated with glycinergic (and some other) neurons is expressed in the cervical region of the spinal cord and the brainstem [35−38] , while GLYT2 preferentially localized in axons, neuritis, in the cerebellum and retina [35, 36, 39, 40] .
There is experimental evidence that GLYT1 pro duction by glial cells requires the presence neurons [36] . The latter suggests existence of cross regulation of both types of cells during initiation and mainte nance of expression of this transporter in the nervous tissue.
Gly transporters are subdivided into subtypes. Two genes, glyt1 and glyt2, encode several isoforms of gly cine transporters: GLYT1a⎯c, e⎯f, and GLYT2a⎯b.
In glycinergic nerve endings GLYT2a is character ized by the stoichiometry of 3Na + /Cl -/Gly; this sug gests effective accumulation of Gly under all physio logical conditions [41] . It performs neuronal reuptake of this amino acid from the synaptic cleft [41] .
In the astrocyte glia GLYT1b is characterized by the stoichiometry of 2Na + /Cl -/Gly; this suggests export (import) of Gly in dependence of physiological conditions. GLYT1b may decrease synaptic Gly con centrations [42] and modulate glutamatergic currents through NMDAR [43, 44] aptic currents followed by the increase in glutamater gic excitatory postsynaptic currents [32] .
A separate group of amino acid transporters is involved in neurotransmitter transport in nerve syn apses. According to localization and action transport ers of this group are subdivided into two subgroups: the subgroup of neurotransmitter transporters responsible for transport across the plasma membrane and the subgroup of neurotransmitter transporters of synaptic vesicles. The latter group includes the GABA/Gly transporter (VIAAT/VGAT) and transporters of monoamines and acetylcholine [34, 45] . The main function of these transporters consists in accumula tion of neurotransmitters for their subsequent use in the synaptic transmission. In addition, it is also sug gested that Gly may entry the cell via simple diffusion [32] .
Thus, both nerve and glial cells contain own spe cific glycine transporters, Gly uptake and Gly cleavage systems, which are responsible not only for coordi nated synthesis of needed subcellular elements but also modulation of neurotransmitter currents. The presence of specific Gly receptors in the nervous tissue is the key element of such regulation.
GLYCINE RECEPTORS AND BINDING SITES ON NERVOUS TISSUE CELLS
Since aminoacetic acid is a metabolite character ized by a wide range of effects in the central and peripheral nervous systems, the nervous tissues should have at least two types of receptors, involved in activa tion of glutamatergic and glycinergic currents.
Four types of receptors, which can bind Gly, are now recognized. These include specific glycine recep tor (GlyR), ionotropic glutamate receptor specifically binding N methyl D aspartate (NMDAR), and also ionotropic receptors of γ aminobutyric acid (GABA A R, GABA C R) ( Table 1) .
GlyR and inonotropic GABA receptors located on the postsynaptic membrane of many neurons are the members of the nicotinic acetylcholine receptor superfamily [46] . All the receptors of this group are ionic channels usually composed of five subunits. Ligand binding to GABAR or GlyR results in the increase of chloride ion level in the target cells and membrane hyperpolarization [46] .
GlyR is a protein possessing quaternary structure. It consists of two types of subunits, α and β. The ratio of these subunits was found to be 4α : 1β [47] (Fig. 2) . These subunits share sequence homology [48] . They are linked together by disulfide bonds and form a long molecule, which spans the cell membrane several times [46] . Each GlyR subunit contains a rather long N terminal extracellular domain exposed to the syn aptic cleft, four transmembrane regions, an intracellu lar loop and a short extracellular C terminus [46] . The ion channel is located between subunits (inside one of the transmembrane regions) (Fig. 2) . The channel demonstrates selective permeability towards anions Cl -, Br -, I
-(in the cell it is mainly Cl -) and sometimes to bicarbonate [46] .
It has been demonstrated that both α and β sub units are involved into interaction with glycine; their (-) ends bind carboxyl group of Gly, while (+) ends bind amino group [46] . Since the distance between ligand binding sites of GlyR and the ion channel is rather short conformation changes in the receptor protein after Gly binding influence channel gating. Although the extracellular domain of homologous receptors has been studied in details the precise mech anism of the GlyR channel gating remains unknown.
For genes encoding various α subunits and one gene encoding β subunits have been found in mam mals to date [49, 50] . β Subunits are responsible for GlyR anchoring in the membrane via their hydropho bic part [48] . Changes in β subunits (within the nor mal range) did not influence receptor activation and its responsiveness [51] . Mechanisms responsible for receptor anchoring in the membrane and its posttrans lational modification still require better understand ing. Expression of genes encoding GlyR α subunits depends on neuron topography; it is also varied in dif ferent periods of ontogenesis. For example, α 1 subunit mRNA and protein have been found in the spinal cord and the brain [52, 53] and also retinal rod cells of adult individuals, while the level of the α 2 protein was max imal at birth [52, 54, 55] . In adults small amounts of this protein were detected in the hippocampus, brain cortex, and thelemus [52, 56] . β Subunits are widely abundant in the mammalian CNS before and after birth [48, 52, 57] . In the adult CNS glycine mainly functions as an inhibitory neurotransmitter, while in embryos it acts as an excitatory neurotransmitter. The latter is possible due to higher concentration of Cl -in embryonic cells than in the extracellular medium and so GlyR channel gating results in membrane depolar ization [47] . This excitatory function of GlyR is important for genesis of synapses. During initial stages of perinatal ontogenesis functioning of the K + /Cl -transporter decreases cellular Cl -and under these conditions GlyR demonstrate the hyperpolarizing function [47] .
The number of GlyR (own specific glycine recep tors) in the membrane depends on their exocito sis/insertion into the membrane, membrane anchor ing by gephyrin, and endocytosis into endosomes [46, 58] . These functions are attributed to cytoplasmic parts of the receptor protein. Postsynaptic receptors are in certain dynamic equilibrium and easily return to cytoplasm.
Distribution of GlyRs in the nervous tissue is higher in the medulla oblongata, pons, and the spinal cord [47, 59] .
GlyR have been found not only in neurons but also in glial cells [60] . Using immunofluorescence specific Gly binding sites have been found in cultures of rat C6 glioma and spinal cord glial cells [60] . The mode of distribution and density of these specific Gly binding sites differ in various cell types. For example, diffuse distribution of these sites was found on the surface of the cultivated glial cells, while concentrated fluores cence of specific Gly binding sites was frequently observed on the surface of neurons [60] .
Recently extrasynaptic GlyRs have been also rec ognized, for example, in CA3 hippocampal neurons and embryonic cortical neurons [61, 62] . It is sug gested that their functional activity associated with neuronal or gliocyte production of such ligands as tau rine and β alanine is important for brain ontogenesis [61, 62] . Certain evidence exists that GlyRs may have presynaptic localization in medial nuclei of the brain trapezoid body [58] . In contrast to classical effect such receptors increased functional activity of neuronal Ca 2+ channels and activation of glutamatergic cur rents [58] .
In contrast to GlyR possessing five reasonably large ligand binding pockets NMDARs have small binding sites for Gly. Nevertheless, the effect of Gly as the glutamate receptor agonist is critical for the function ing of the whole nervous system, because it is generally accepted that glutamate is the main neurotransmitter in the nervous system. Gly itself does not induced a NMDAR mediated response but increases frequency of channel gating without influence of the amplitude of NMDA receptor agonist induced currents [29, 46] . However, in the absence of Gly L glutamate could not activate NMDAR [46] .
Maximal activation of NMDAR by Gly was observed in the hippocampus, hemisphere cortex, cer ebellum, anterior and midbrain, thalamus, striatum, and the olfactory bulb (Table 1 ) [29] . Frequently, stud ies of glutamate ionotropic receptors are targeted to regulation of neuron regulation in the CNS; however, certain evidence for the presence of NMDAR on glial cells also exists [33, 46, 63, 64] .
In some cases Gly does not act as the main inhibi tory neurotransmitter. First, mixed GABA Gly syn apses may induce neurotransmission in the spinal cord, brain stem or cerebellum [65, 66] . Second, Gly exhibit its inhibitory activity during interaction with GlyR and also with GABA A and GABA C receptors [67] .
Since Gly acts at receptor systems with opposite functional roles it is reasonable to suggest that this neurotransmitter plays a critical role for numerous physiological and pathological processes in the body.
THE ROLE OF GLYCINE RECEPTOR
FOR FUNCTIONAL ACTIVITY OF THE NERVOUS SYSTEM Although replaceable amino acids are not ulti mately required for growth of cultivated cells, how ever, their presence often stimulates cell growth.
For example, glycine additions increased cell mass of fibroblast [68] , C6 glioma [14, 16, 17, 20] cell line; in experiments on the spinal cord primary cultures of the newborn rats 0.01 or 0.1 mM Gly increased the number of cells of the Nissl tigroid substance [13, 16] . NMDAR activation increased proliferative activity of Muller glial cells, which could restore damaged retinal cells [69] .
In this context a reasonable question arises: how can the replaceable amino acid stimulate the prolifer ative activity of nerve tissue cells?
First, some amino acids (Gly, GABA, glutamate, aspartate, etc.) actively influence the membrane potential of nerve cells and this can significantly influ ence developmental events.
For example, Gly may not necessarily influence the membrane potential or induce membrane hyperpolar ization (of spinal cord motoneurons). In embryonic neurons extracellular concentration of chloride ions is much higher than in mature neurons and so this amino acid can induce membrane depolarization required for Ca 2+ entry to the cell and subsequent formation of glycinergic synapses [47] . Second, the presence of GlyR on gliacytes [60] and neurons [60, 62] suggests that within a certain concentration range selective stimulation of neuron proliferation and simultaneous inhibition of gliacyte proliferation are quite possible.
The stimulation of the proliferative activity of cells by Gly may be realized at least by three pathways [63, 70−73] including:
-changes in intracellular Ca 2+ concentrations, -changes in cell membrane potential, -changes in intracellular cAMP concentrations. Glycine acting at GlyR, GABAR, and NMDAR, which are abundant on the neuron and gliacyte plasma membranes, is actively involved in all these processes [24, 63, [74] [75] [76] [77] .
It was demonstrated that changes of intracellular Ca 2+ concentration and cell membrane potential may be involved in regulation of the cell proliferation rate. For example, the increase in proliferation of Ehrich ascite carcinoma cells was accompanied by the increase of intracellular Ca 2+ and a decrease of mem brane potential [70] . It is generally accepted now that intracellular signaling realized by these regulators as determined by their oscillations [70] and their decreased amplitudes may be a signal that triggers cell division [70] .
Intracellular cAMP concentrations influence pro liferation and differentiation of nerve cells [73, 78, 79] . It is believed that increased intracellular cAMP con centrations inhibit cell proliferation because of induc tion of oligoadenylate syntetase responsible for syn thesis of 2',5' oligoadenylate [71, 72] . A stable increase in the intracellular level of 2',5' oligoadeny late causes cell transition from proliferation to the resting state [71, 72] .
It should be noted that changes of intracellular Ca 2+ and cAMP concentrations and also changes of membrane potential trigger activation of intracellular protein kinases including mitogen activated protein kinases (MAPK), which regulate gene expression, division and proliferation of cells. Thus, any compo nents of this process is able to induce proliferation of nerve tissue cell.
Thus, acting at GlyR this amino acid can initiate a cascade of events influencing cell cycle, differentia tion, and proliferation of cells.
Gly induced changes of the proliferative and func tional activity of the transplanted C6 glioma cell cul ture may involve both GABAR and GlyRs, which are highly abundant on the plasma membranes of these cells [63] , while changes in such activity of spinal cord cells involve NMDAR, GABAR, and GlyRs. How ever, it should be noted that these receptors are not the only regulators of the Gly mediated ion currents in the nervous tissue.
Regulating Gly levels in the extracellular space GLYT1 and GLYT2 influence cell membrane poten tial and intracellular ion currents, which can increase functional activity of cells via some chemical reac tions. For example, it was demonstrated that stimula tion of the Na + /H + antiporter of C6 glioma cells caused cytosol alkalinization followed by subsequent activation of glycolysis, oxidative phosphorylation, and Na + /K + pump, which significantly increased via bility of this cell culture [63] . It was also demonstrated that in normal and differentiated tumor astrocytes the membrane potential of -70 mV differed from that of non differentiated tumor astrocytes (-40 mV) and C6 cells had significantly higher Ca 2+ dependent uptake of K + ions that other glial cell cultures.
It should be noted that GlyRs are not only involved in signal transmission from sensor neurons to moto neurons; they are also participate in pain perception, photosignal transduction and the development of the nervous system [80] [81] [82] [83] . Gly synapses are also impor tant for light perception by retina. Various retinal cells contain GlyRs composed of different subunits [82] ; although they may exist within the same layer there is evidence that probability for their co localization in the same synapse is less that 10% [82] . Thus, one syn apse contains just one type of GlyR and it appears that different types of such receptors play different role in the retina.
Besides Gly, taurine also inhibits neurons. It is released by extrasynaptic cells during embryogenesis and its developmental effects are realized by extrasyn aptic GlyRs containing α 2 subunits [81] . Acting at these receptors taurine regulates number of rods in the developing retina. Although nerve cells interact with each other by means of synapses extrasynaptic recep tors also exist [81] . It appears that their role consist in perception of a relatively weak untargeted signal under conditions of non vesicular release of the transmitter and/or during neurotransmitter diffusion from adja cent synapses. Thus, it is possible that the presence of GlyRs containing α 2 subunits is needed in the thala mus and hippocampus for weak (tonic) neuron inhibi tion by taurine. Here it should be reminded again that Gly is involved in activation of ionotropic glutamate receptors required for formation of synaptic plasticity and memory development [83] . Gly influences various links of nerve structure formation during embryonic and postnatal development.
Strychnine, the main Gly antagonist consists in the constant excitation of motoneurons, sensor neurons, and in enhanced pain perception [80] . In the dorsal horn of the spinal cord sensor neurons form synapses with interneurons, the primary integration center for analysis of pain information, where a network of inhibitory neurons regulates subsequent signal trans duction to the brain. Blocking GlyR, strychnine causes a multifold increase of pain feelings. Stimula tion of GlyR may attenuate pain [80] and this is the task for subsequent studies in pain relief and anesthe sia. Possibility of anesthesia by means of augmentation of GlyRs generated currents is an important problem of modern medicine.
It is known that among the whole family of iono tropic receptors, GlyR is the only receptor lacking a metabotropic analogue. Although GlyR is not directly coupled to the G protein, certain evidence exists that it can be modulated by G protein βγ subunits [84] . This results in the transient increase of the ion current through this channel. This fact may be used in the future for potentiation of the GlyR response to a regu latory signal.
Experiments with labeled Gly have shown that it is derived from glucose carbohydrate chains and is a building block for structural proteins and cell phos pholipids [68] , and also for the main water soluble antioxidant, glutathione [85, 86] , purine bases, creat ine and porphyrins [87, 88] . There is evidence that Gly can bind large amound of toxic substances (aldehydes, ketone) formed during ischemia and protect brain cells against excessive action of catecholamines during brain infarction [89, 90] . CONCLUSIONS Thus, Gly exhibits general metabolic, neuropro tector and regulatory effects of the nervous system. These effects have been employed in various Gly based drug preparations developed for treatment of brain infarction, nauropathy, epilepsy, convulsive states, schizophrenia, various neurodegenerative dis eases and dementias. Table 2 summarizes the main physiological effects of Gly in the mammalian nervous system and some mechanisms of their realization.
In general, the structure of GlyR has been studied in details; however, mechanisms of their functioning still remain poorly investigated. The latter may be explained by the absence of highly selective ligands for these receptors and abundant expression of receptors of glutamate, Gly, GABA, and cholinergic systems demonstrating diverse effects in the same nerve struc tures. Studies of Gly properties are important for physiology of mammals and medicine. Methods for elucidation of various function of different glycine receptor isoforms and mechanisms of regulation of their activity in the CNS have already been developed.
Analysis of the literature data has shown that Gly is essential for realization of most biological processes in the nervous system. This amino acid not only provides a metabolic basis for restoration of structural elements of nervous and glial cells but is actively involved in the regulation of such compex processes as cell cycle, pro tection of nervous tissue cells under unfavorable con ditions, pain perception, photosignal transduction, ontogenesis of the nervous system, activation of iono tropic glutamate receptors required for formation of synaptic plasticity and memory development.
Elucidation of the role of this amino acid is of pri marily importance for understanding of molecular Antioxidant defense [85, 86] .
Gly glutathione synthesis, binding of ketones and aldehydes inhi bition of lipid peroxidation and a decrease of formation oxidative stress prod ucts.
General metabolic function [68, 85⎯89, 93] .
Gly synthesis of glucose, purine bases, creatine, porphyrins and phos pholipids.
Nervous system development in ontogenesis [47, 61, 62, 81, 83] Formation of memory, learning, improvement of mental capacities (neurometabolic stimulator) [29, 32, 33, 43, 44, 58] .
NMDARs activation synaptic plasticity memory and learning.
Brain resistance to aggressive treatments and psy chology normalization [68, [85] [86] [87] [88] [89] [91] [92] [93] .
General metabolic, neuroprotective and regulatory effects of glycine (reali zed via GlyRs and NMDARs Gly site).
Regulation of retinal functions [65, 66, 67, 81] . Via mechanisms of cross reactivity of GABA and Gly ergic synapses.
mechanisms of such processes as cell division, differ entiation, adaptive rearrangements of nervous and glial cell elements in cell cultures. The functional and metabolic effects of Gly on nervous and glial cells in vitro still remain poorly understood and therefore there is clear need for subsequent studies in this field.
